mesowatch
mesowatch
Patricia Shelton

Reading Time: 11 mins

Last Modified: March 6, 2024

Page Features:6 cited research

Patricia Shelton - author

Dr. Patti Shelton reviews medical information on the site for accuracy. She holds both a Doctor of Medicine degree as well as a Bachelor’s degree in neuroscience from the University of Washington in Seattle. Her work focuses on communicating scientific information to the public and helping make complex concepts understandable so that patients can make their own informed decisions. She also teaches anatomy and physiology courses at the college level. 

Jump to a topic


Related Pages

divider

warning icon

Find out if you qualify for a mesothelioma lawsuit.

What is Mesothelioma?

What is Mesothelioma?

Patricia Shelton

Reading Time: 11 mins

Last Modified: March 6, 2024

Page Features:6 cited research

Patricia Shelton - author

Dr. Patti Shelton reviews medical information on the site for accuracy. She holds both a Doctor of Medicine degree as well as a Bachelor’s degree in neuroscience from the University of Washington in Seattle. Her work focuses on communicating scientific information to the public and helping make complex concepts understandable so that patients can make their own informed decisions. She also teaches anatomy and physiology courses at the college level. 

Jump to a topic


warning icon

Find out if you qualify for a mesothelioma lawsuit.

6 References

divider

VIEW 0 MORE REFERENCES

Related Content

divider
Johnson & Johnson’s $6.5B Settlement: Long-Term Effect on Future Claims
Johnson & Johnson’s $6.5B Settlement: Long-Term Effect on Future Claims

Melissa Bill
4 mins read - May 7, 2024

Johnson & Johnson is on the verge of settling more than 50,000 lawsuits alleging that the use of its widely-used talc baby powder led to claimants developing ovarian cancer....

Settlements

Illinois Jury Awards $45M in J&J Baby Powder Case
Illinois Jury Awards $45M in J&J Baby Powder Case

Melissa Bill
3 mins read - May 3, 2024

On Friday, an Illinois court ordered Johnson & Johnson and Kenvue to pay $45 million in a case that involved a family that alleged a link between the relative’s death after...

Settlements

Revolutionizing Mesothelioma Care: New Treatment Era with ADI-PEG20
Revolutionizing Mesothelioma Care: New Treatment Era with ADI-PEG20

Mary Pieper
3 mins read - May 2, 2024

In the ongoing battle against mesothelioma, the introduction of ADI-PEG20 (pegargiminase) marks a significant milestone. This innovative drug, hailed for its novel approach,...

Treatment

© 2024 Mesowatch. All right reserved.